JP2007527902A5 - - Google Patents

Download PDF

Info

Publication number
JP2007527902A5
JP2007527902A5 JP2007502348A JP2007502348A JP2007527902A5 JP 2007527902 A5 JP2007527902 A5 JP 2007527902A5 JP 2007502348 A JP2007502348 A JP 2007502348A JP 2007502348 A JP2007502348 A JP 2007502348A JP 2007527902 A5 JP2007527902 A5 JP 2007527902A5
Authority
JP
Japan
Prior art keywords
alkyl
phenyl
hydrogen
group
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007502348A
Other languages
English (en)
Japanese (ja)
Other versions
JP4856623B2 (ja
JP2007527902A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/051086 external-priority patent/WO2005087724A2/en
Publication of JP2007527902A publication Critical patent/JP2007527902A/ja
Publication of JP2007527902A5 publication Critical patent/JP2007527902A5/ja
Application granted granted Critical
Publication of JP4856623B2 publication Critical patent/JP4856623B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007502348A 2004-03-11 2005-03-10 新規のｎ−スルホニルピロール誘導体 Expired - Lifetime JP4856623B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04101003 2004-03-11
EP04101003.4 2004-03-11
PCT/EP2005/051086 WO2005087724A2 (en) 2004-03-11 2005-03-10 Sulphonylpyrroles as hdac inhibitors

Publications (3)

Publication Number Publication Date
JP2007527902A JP2007527902A (ja) 2007-10-04
JP2007527902A5 true JP2007527902A5 (https=) 2008-04-10
JP4856623B2 JP4856623B2 (ja) 2012-01-18

Family

ID=34928899

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007502348A Expired - Lifetime JP4856623B2 (ja) 2004-03-11 2005-03-10 新規のｎ−スルホニルピロール誘導体

Country Status (25)

Country Link
US (5) US7842820B2 (https=)
EP (2) EP1725528B1 (https=)
JP (1) JP4856623B2 (https=)
KR (1) KR101130556B1 (https=)
CN (1) CN1926103B (https=)
AR (1) AR048427A1 (https=)
AU (1) AU2005221834B2 (https=)
BR (1) BRPI0508464B8 (https=)
CA (1) CA2558552C (https=)
CY (1) CY1114284T1 (https=)
DK (1) DK1725528T3 (https=)
EA (1) EA012451B1 (https=)
ES (1) ES2430371T3 (https=)
HR (1) HRP20130810T1 (https=)
IL (1) IL177168A (https=)
ME (1) ME02122B (https=)
NO (1) NO337457B1 (https=)
NZ (1) NZ549251A (https=)
PL (1) PL1725528T3 (https=)
PT (1) PT1725528E (https=)
RS (1) RS52937B (https=)
SI (1) SI1725528T1 (https=)
TW (1) TWI353977B (https=)
WO (1) WO2005087724A2 (https=)
ZA (1) ZA200606315B (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2256106T3 (pl) 2003-07-22 2015-08-31 Astex Therapeutics Ltd Związki 3,4-pochodne 1h-pirazolu i ich zastosowanie jako kinazy zależne od cyklin (cdk) i modulatory kinazy syntazy glikogenu-3 (gsk-3)
HRP20130810T1 (en) 2004-03-11 2013-09-30 4Sc Ag Sulphonylpyrroles as hdac inhibitors
US8404718B2 (en) 2005-01-21 2013-03-26 Astex Therapeutics Limited Combinations of pyrazole kinase inhibitors
AR054425A1 (es) 2005-01-21 2007-06-27 Astex Therapeutics Ltd Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
MX2007008781A (es) * 2005-01-21 2007-09-11 Astex Therapeutics Ltd Compuestos farmaceuticos.
PT1861365E (pt) * 2005-03-15 2009-09-22 4Sc Ag N-sulfonilpirroles e a sua utilização como inibidores de histona-desacetilase
EP1868994B1 (en) * 2005-04-07 2011-05-25 4Sc Ag Sulfonylpyrroles as histone deacetylase inhibitors
NZ541788A (en) * 2005-08-11 2007-12-21 Auckland Uniservices Ltd Conducting polymers and their use in oligonucleotide (ODN) probes
CN101287706A (zh) * 2005-09-21 2008-10-15 尼科梅德有限责任公司 作为组蛋白脱乙酰基酶抑制剂的磺酰基吡咯盐酸盐
BRPI0617167B8 (pt) * 2005-09-21 2021-05-25 Nycomed Gmbh sulfonilpirróis como inibidores de hdac's, seu uso, composição farmacêutica e combinação
PT1975158E (pt) * 2005-12-27 2011-09-23 Ct Nac Investigaciones Oncologicas Cnio Novos derivados de pirrole com actividade inibidora de histona desacetilase
EP2100882A1 (en) * 2008-03-12 2009-09-16 4Sc Ag (E) -N -(2-Amino-phenyl) -3-{1-[4-(1-methyl-1H-pyrazol-4-yl)- benzenesulfonyl]-1H-pyrrol-3-yl} -acrylamide salts
EP2100878A1 (en) 2008-03-12 2009-09-16 4Sc Ag Novel method for the production of sulphonylpyrroles as HDAC inhibitors
ES2605815T3 (es) * 2008-07-01 2017-03-16 Ptc Therapeutics, Inc. Moduladores de la expresión de la proteína Bmi-1
EP2330894B8 (en) 2008-09-03 2017-04-19 BioMarin Pharmaceutical Inc. Compositions including 6-aminohexanoic acid derivatives as hdac inhibitors
CN101941948A (zh) * 2009-07-10 2011-01-12 南开大学 点击化学合成具有分支结构的组蛋白去乙酰酶抑制剂
US10059723B2 (en) 2011-02-28 2018-08-28 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
US9540395B2 (en) 2011-02-28 2017-01-10 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
US8957066B2 (en) 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
WO2014143666A1 (en) 2013-03-15 2014-09-18 Biomarin Pharmaceutical Inc. Hdac inhibitors
EP3062783B1 (en) 2013-10-18 2020-08-12 The General Hospital Corporation Imaging histone deacetylases with a radiotracer using positron emission tomography
KR102359214B1 (ko) 2014-04-04 2022-02-07 델 마 파마슈티컬스 폐의 비소세포 암종 및 난소암을 치료하기 위한 디안하이드로갈락티톨 및 이의 유사체 또는 유도체
CN105801464B (zh) * 2014-12-29 2019-05-28 成都先导药物开发有限公司 吡咯酰胺类化合物及其制备方法与用途
WO2017178577A1 (en) 2016-04-14 2017-10-19 4Sc Ag Medical application of resminostat in asian patients
TW201912183A (zh) 2017-08-31 2019-04-01 德商４Ｓｃ製藥公司 Hdac抑制劑與抗代謝藥劑組合用於癌症治療
WO2019200238A1 (en) 2018-04-14 2019-10-17 Dynavax Technologies Corporation Combinations including a cpg-c type oligonucleotide and a histone deacetylase inhibitor for treating cancer
CA3097087A1 (en) 2018-04-17 2019-10-24 4Sc Ag Combination comprising hdac inhibitor, lag-3 inhibitor and a pd-1 inhibitor or pd-l1 inhibitor for cancer treatment
TW202114659A (zh) 2019-10-02 2021-04-16 德商４Ｓｃ製藥公司 用於癌症治療之含ｈｄａｃ抑制劑、ｃｔｌａ—４抑制劑及ｐｄ—１抑制劑或ｐｄ—ｌ１抑制劑之組合

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4960787A (en) * 1989-02-06 1990-10-02 Ciba-Geigy Corporation Certain pyrrolyl-substituted hydroxamic acid derivatives
KR100236806B1 (ko) 1991-12-10 2000-01-15 시오노 요시히코 방향족 설폰아미드계 하이드록삼산 유도체
CA2223154A1 (en) * 1995-06-02 1996-12-05 G.D. Searle & Co. Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
JP2003514905A (ja) 1999-11-23 2003-04-22 メルク エンド カムパニー インコーポレーテッド ピラジノン系トロンビン阻害薬
KR20020070285A (ko) * 1999-11-23 2002-09-05 메틸진, 인크. 히스톤 디아세틸라제의 억제제
US6521618B2 (en) * 2000-03-28 2003-02-18 Wyeth 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
MXPA04001253A (es) * 2001-08-09 2004-06-03 Ono Pharmaceutical Co Derivados de acidos carboxilicos y agente farmaceutico que comprende los mismos como ingrediente activo.
EP1429765A2 (en) 2001-09-14 2004-06-23 Methylgene, Inc. Inhibitors of histone deacetylase
US7868204B2 (en) * 2001-09-14 2011-01-11 Methylgene Inc. Inhibitors of histone deacetylase
ES2306859T3 (es) * 2002-03-13 2008-11-16 Janssen Pharmaceutica Nv Derivados de sulfonil como nuevos inhibidores de histona deacetilasa.
AU2003298567B9 (en) 2002-08-29 2009-07-23 Temple University - Of The Commonwealth System Of Higher Education Aryl and heteroaryl propene amides, derivatives thereof and therapeutic uses thereof
GB0226855D0 (en) 2002-11-18 2002-12-24 Queen Mary & Westfield College Histone deacetylase inhibitors
EP1663204B1 (en) 2003-08-29 2014-05-07 Exelixis, Inc. C-kit modulators and methods of use
US20080242681A1 (en) 2004-01-22 2008-10-02 Altana Pharma Ag N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors
US20050197336A1 (en) 2004-03-08 2005-09-08 Miikana Therapeutics Corporation Inhibitors of histone deacetylase
HRP20130810T1 (en) * 2004-03-11 2013-09-30 4Sc Ag Sulphonylpyrroles as hdac inhibitors
US7345043B2 (en) * 2004-04-01 2008-03-18 Miikana Therapeutics Inhibitors of histone deacetylase
GB2415703A (en) 2004-07-02 2006-01-04 Hewlett Packard Development Co Liquid crystal display device
UA87884C2 (uk) 2004-12-03 2009-08-25 Мерк Энд Ко., Инк. Безводна кристалічна калієва сіль інгібітора віл-інтегрази
US7432808B2 (en) 2004-12-15 2008-10-07 Intel Corporation Wireless module enabled component carrier for parts inventory and tracking
EP1831173B1 (en) 2004-12-17 2011-01-26 Janssen Pharmaceutica NV Tetrahydroisoquinoline compounds for treatment of cns disorders
PT1861365E (pt) 2005-03-15 2009-09-22 4Sc Ag N-sulfonilpirroles e a sua utilização como inibidores de histona-desacetilase
EP1868994B1 (en) * 2005-04-07 2011-05-25 4Sc Ag Sulfonylpyrroles as histone deacetylase inhibitors
BRPI0617167B8 (pt) 2005-09-21 2021-05-25 Nycomed Gmbh sulfonilpirróis como inibidores de hdac's, seu uso, composição farmacêutica e combinação
CN101287706A (zh) * 2005-09-21 2008-10-15 尼科梅德有限责任公司 作为组蛋白脱乙酰基酶抑制剂的磺酰基吡咯盐酸盐
EP2060565A1 (en) * 2007-11-16 2009-05-20 4Sc Ag Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
EP2100882A1 (en) * 2008-03-12 2009-09-16 4Sc Ag (E) -N -(2-Amino-phenyl) -3-{1-[4-(1-methyl-1H-pyrazol-4-yl)- benzenesulfonyl]-1H-pyrrol-3-yl} -acrylamide salts

Similar Documents

Publication Publication Date Title
JP2007527902A5 (https=)
Vergani et al. Novel benzohydroxamate-based potent and selective histone deacetylase 6 (HDAC6) inhibitors bearing a pentaheterocyclic scaffold: design, synthesis, and biological evaluation
US8785489B2 (en) Heteroaryl substituted indole compounds useful as MMP-13 inhibitors
Seal et al. The optimization of a novel, weak bromo and extra terminal domain (BET) bromodomain fragment ligand to a potent and selective second bromodomain (BD2) inhibitor
JP6531100B2 (ja) キナーゼ阻害剤としての置換ニコチンアミド誘導体
JP6326057B2 (ja) 置換ピリミジニルおよびピリジニル−ピロロピリジノン、これらの調製のための方法、およびキナーゼ阻害剤としてのこれらの使用
JP6017313B2 (ja) 化合物および方法
JP7241025B2 (ja) 選択的ｈｄａｃ６阻害剤
JP2012510989A5 (https=)
JP5524173B2 (ja) 抗増殖性化合物およびその治療的使用
JP7175888B2 (ja) 選択的ｈｄａｃ１、２阻害剤としてのピペラジン誘導体
RU2006117635A (ru) Производные индолинона и их применение для лечения патологических состояний, таких как злокачественное новообразование
Spicer et al. Exploration of a series of 5-arylidene-2-thioxoimidazolidin-4-ones as inhibitors of the cytolytic protein perforin
RU2009104770A (ru) Производные пиримидина в качестве ингибиторов alk-5
JP2010513304A5 (https=)
JP2016135778A (ja) シアノトリアゾール化合物の医薬用途
CA2453175A1 (en) Interaction inhibitors of tcf-4 with beta-catenin
EA014245B1 (ru) Аналоги арилпропионамида, арилакриламида, арилпропинамида или арилметилмочевины в качестве ингибиторов фактора xia
JP2020516671A5 (https=)
RU2007117913A (ru) 2, 6-замещенные-4-монозамещенный амино-пиримидины как антагонисты рецептора простагландина d2
RU2017144535A (ru) Мультизамещенные ароматические соединения в качестве ингибиторов тромбина
Lorthiois et al. Discovery of highly potent and selective small-molecule reversible factor D inhibitors demonstrating alternative complement pathway inhibition in vivo
JP2020520354A5 (https=)
JP2011510985A5 (https=)
Yu et al. Discovery of ethyl ketone-based highly selective HDACs 1, 2, 3 inhibitors for HIV latency reactivation with minimum cellular potency serum shift and reduced hERG activity